Orient Pharma Co Ltd

NEW
ROCO:4166 (Taiwan)  
NT$ 24.7 -0.050 (-0.2%) Sep 1
25.00
P/B:
2.26
Market Cap:
NT$ 6.00B ($ 189.21M)
Enterprise V:
NT$ 5.61B ($ 176.75M)
Volume:
123.09K
Avg Vol (2M):
201.36K
Trade In:
Volume:
123.09K
Avg Vol (2M):
201.36K

Orient Pharma Co Ltd (ROCO:4166) Dividend

Orient Pharma Co Ltd (ROCO:4166) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -9.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ROCO:4166 Dividend

Does Orient Pharma Co Ltd (ROCO:4166) pay a dividend?

Orient Pharma Co Ltd (ROCO:4166) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Orient Pharma Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Orient Pharma Co Ltd has returned capital to shareholders via buybacks at a rate of -9.1% over the past 3 years.

What are dividend-paying alternatives to Orient Pharma Co Ltd?

For dividend-paying alternatives in Orient Pharma Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.